First Eagle Investment Management LLC Raises Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

First Eagle Investment Management LLC increased its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 17.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 292,278 shares of the company’s stock after acquiring an additional 43,100 shares during the period. First Eagle Investment Management LLC owned approximately 0.23% of Surgery Partners worth $6,188,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in SGRY. Raymond James Financial Inc. bought a new stake in shares of Surgery Partners during the fourth quarter valued at approximately $10,130,000. Charles Schwab Investment Management Inc. raised its position in shares of Surgery Partners by 8.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 834,417 shares of the company’s stock worth $17,665,000 after purchasing an additional 61,671 shares during the last quarter. NINE MASTS CAPITAL Ltd acquired a new position in shares of Surgery Partners during the 4th quarter worth about $606,000. Versor Investments LP grew its stake in Surgery Partners by 450.0% during the 4th quarter. Versor Investments LP now owns 46,200 shares of the company’s stock valued at $978,000 after acquiring an additional 37,800 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of Surgery Partners by 17.7% in the 4th quarter. Bank of New York Mellon Corp now owns 340,776 shares of the company’s stock valued at $7,214,000 after buying an additional 51,187 shares during the period.

Surgery Partners Trading Down 0.0 %

NASDAQ SGRY opened at $23.60 on Friday. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $33.97. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The company has a market capitalization of $3.01 billion, a price-to-earnings ratio of -49.17, a price-to-earnings-growth ratio of 19.21 and a beta of 2.73. The company’s fifty day moving average price is $23.58 and its two-hundred day moving average price is $26.04.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.01. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm had revenue of $864.40 million for the quarter, compared to the consensus estimate of $828.09 million. As a group, research analysts predict that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on SGRY shares. Bank of America started coverage on shares of Surgery Partners in a research report on Monday, December 16th. They set a “buy” rating and a $30.00 price objective for the company. JPMorgan Chase & Co. lowered their target price on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research report on Tuesday, December 3rd. Royal Bank of Canada lowered their target price on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 20th. Finally, Macquarie lowered their target price on shares of Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Surgery Partners currently has a consensus rating of “Moderate Buy” and a consensus target price of $36.63.

Insider Transactions at Surgery Partners

In related news, CFO David T. Doherty sold 6,733 shares of Surgery Partners stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now directly owns 150,868 shares in the company, valued at $3,623,849.36. This trade represents a 4.27 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Marissa Brittenham sold 3,156 shares of Surgery Partners stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $24.09, for a total transaction of $76,028.04. Following the completion of the sale, the insider now owns 63,408 shares in the company, valued at approximately $1,527,498.72. This represents a 4.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 106,622 shares of company stock worth $2,717,860. 2.30% of the stock is currently owned by insiders.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.